| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months (pa) | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | Harvest Lane Asset Management employs a conservative, highly selective and opportunistic approach. Using their extensive knowledge in the area of corporate actions, the Fund's managers assess each opportunity based on a thoughtful, diligent and disciplined process and invest where they believe an opportunity exists to generate above average investment returns relative to the risk incurred. Investment decisions are made without speculating on market direction, with rigid risk controls enforced to minimise the risk of large losses of investor capital. The Fund invests in securities that are predominantly listed on the ASX and occasionally in those listed in other developed markets. Equity swaps and other derivatives may be used at times to reduce risk. The fund typically holds high levels of cash in the absence of sufficiently attractive opportunities to deploy investor capital in accordance with its objectives. |
| Manager Comments | The Harvest Lane Absolute Return Fund rose +1.66% in August. Since inception in July 2013, the Fund has returned +4.99% p.a. with an annualised volatility of 10.57%. The Fund has maintained a down-capture ratio for performance since inception of 16.29% which indicates that, on average, the Fund has significantly outperform during the market's negative months. Harvest Lane saw a lull in corporate activity during August as the market paused to assess the damage during reporting season. However, they noted this lull didn't last for long having seen a flurry of activity in the first week of September. Harvest Lane highlighted the transaction between Abano Healthcare (ABA.NZX) and BGH Capital as one of the most interesting they witnessed during the month. BGH Capital walked away from a NZ$5.70 per share transaction in March by relying on a Material Adverse Change (MAC) clause to exit the deal. The revised deal was struck at a lower headline price of NZ$4.45 with the added condition that the new deal could not be terminated due to a material adverse change. Other key transactions throughout the month are discussed in more detail in the latest performance report. Overall, Harvest Lane are pleased with the Fund's performance in August and expect September to be the same. They noted they continue to make progress making up the portfolio's recent underperformance and are genuinely encouraged by the level of corporate activity they are currently witnessing. |
| More Information |
